Skip to main content

Table 2 CD13, CD33 and HLA-DR expression in AML patients

From: The prospective prognostic value of the immune checkpoint BTLA expression in adult acute myeloid leukemia patients

 

CD13 expression

CD33 expression

HLA-DR expression

AML patients

52 CD13+/8 CD13

52 CD33+/8 CD33

36 HLA-DR+/24 HLA-DR